Total Payments
$3,050
2024 Payments
$514.51
Companies
35
Transactions
179
Medicare Patients
9,997
Medicare Billing
$550,344
Payment Breakdown by Category
Food & Beverage$3,050 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,050 | 179 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $414.12 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $276.55 | 15 | $0 (2024) |
| PFIZER INC. | $270.87 | 18 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $229.51 | 13 | $0 (2022) |
| Amgen Inc. | $197.37 | 12 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $178.29 | 11 | $0 (2024) |
| Novo Nordisk Inc | $150.01 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $144.93 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $137.04 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $129.09 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $514.51 | 33 | ABBVIE INC. ($137.56) |
| 2023 | $750.16 | 42 | ABBVIE INC. ($210.53) |
| 2022 | $898.78 | 48 | Bayer HealthCare Pharmaceuticals Inc. ($128.21) |
| 2021 | $886.78 | 56 | Amgen Inc. ($166.09) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Endocrinology | ||||||
| 10/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Cardio-renal | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: OUD | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: DIABETES | ||||||
| 08/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Gastroenterology | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: OUD | ||||||
| 06/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Endocrinology | ||||||
| 06/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Gastroenterology | ||||||
| 05/10/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Gastroenterology | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 03/01/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Gastroenterology | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,355 | 5,683 | $349,516 | $130,483 |
| 2022 | 35 | 2,509 | 5,931 | $357,513 | $142,523 |
| 2021 | 40 | 2,551 | 6,047 | $366,323 | $156,317 |
| 2020 | 39 | 2,582 | 5,735 | $347,524 | $121,021 |
Total Patients
9,997
Total Services
23,396
Medicare Billing
$550,344
Procedure Codes
145
All Medicare Procedures & Services
145 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 534 | $115,943 | $36,776 | 31.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,740 | $54,780 | $31,191 | 56.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $39,812 | $16,454 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 144 | $20,828 | $7,025 | 33.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 80 | 81 | $7,695 | $5,809 | 75.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 210 | 538 | $10,222 | $4,495 | 44.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 192 | 290 | $13,050 | $3,793 | 29.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 22 | 24 | $6,000 | $3,355 | 55.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 195 | 330 | $7,590 | $2,505 | 33.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 83 | $3,652 | $2,396 | 65.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 178 | 227 | $8,399 | $2,349 | 28.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 159 | 284 | $7,952 | $2,347 | 29.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 96 | 209 | $6,061 | $1,973 | 32.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 70 | 106 | $5,724 | $1,745 | 30.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 51 | 54 | $5,022 | $1,567 | 31.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 119 | $6,773 | $968.35 | 14.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 32 | 32 | $7,908 | $825.28 | 10.4% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 14 | 21 | $1,995 | $807.87 | 40.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 38 | 38 | $3,990 | $718.96 | 18.0% |
| 83550 | Iron binding capacity | Office | 2023 | 38 | 57 | $1,482 | $488.49 | 33.0% |
| 80076 | Liver function blood test panel | Office | 2023 | 51 | 59 | $1,947 | $472.59 | 24.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 31 | $2,790 | $420.00 | 15.1% |
| 83540 | Iron level | Office | 2023 | 38 | 57 | $1,368 | $361.38 | 26.4% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 63 | 110 | $1,100 | $342.10 | 31.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 19 | 23 | $1,058 | $339.94 | 32.1% |
About Rachel Smith, NP-C
Rachel Smith, NP-C is a Family healthcare provider based in Cleveland, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2016. The National Provider Identifier (NPI) number assigned to this provider is 1407208283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rachel Smith, NP-C has received a total of $3,050 in payments from pharmaceutical and medical device companies, with $514.51 received in 2024. These payments were reported across 179 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,050).
As a Medicare-enrolled provider, Smith has provided services to 9,997 Medicare beneficiaries, totaling 23,396 services with total Medicare billing of $550,344. Data is available for 4 years (2020–2023), covering 145 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Cleveland, GA
- Active Since 07/06/2016
- Last Updated 05/21/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1407208283
Products in Payments
- VRAYLAR (Drug) $297.31
- Kerendia (Drug) $276.55
- ELIQUIS (Drug) $273.98
- JARDIANCE (Drug) $188.97
- SOLIQUA 100/33 (Biological) $176.75
- XIFAXAN (Drug) $137.04
- UBRELVY (Drug) $112.00
- Aimovig (Biological) $99.58
- Korlym (Drug) $97.67
- LEQVIO (Drug) $93.92
- BREZTRI (Drug) $82.25
- TRINTELLIX (Drug) $66.82
- Ozempic (Drug) $60.09
- MOUNJARO (Drug) $57.45
- REXULTI (Drug) $54.04
- TOUJEO (Biological) $52.76
- Rybelsus (Drug) $52.40
- ENTRESTO (Drug) $51.01
- Otezla (Drug) $50.24
- Heplisav-B (Drug) $46.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Cleveland
Jateum Blackburn, Fnp-C, FNP-C
Family — Payments: $113,934
Family $113,934
Jodi Rose, Np, NP
Family — Payments: $52,180
Family $52,180
Mrs. Tina Corkwell, Cnp, CNP
Family — Payments: $48,521
Family $48,521
Christina Gast, Np, NP
Family — Payments: $41,325
Family $41,325
Sarah Demko, Cnp, CNP
Family — Payments: $26,912
Family $26,912
Barton Nakdimen, Aprn-Bc, APRN-BC
Family — Payments: $10,749
Family $10,749